Category Archives: Genetic Engineering

Daniel Estulin: The Coming Age of Human Deconstruction
Michael Cross, author of the "Freedom from Conscience" series and host of "Unlock the Door" radio interviews Daniel Estulin, author of "TransEvolution: The C...

By: Michael Cross

See the rest here:
Daniel Estulin: The Coming Age of Human Deconstruction - Video

A farmers' body affiliated to the CPI(M) on Saturday criticised the decision of the Genetic Engineering Approval Committee (GEAC) to revalidate the field trials for 10 varieties of Genetically Modified (GM) food crops and sought the Election Commission's intervention to "stall the undemocratic move."

"This decision is a bonanza given on the eve of the elections to the Indian and MNC agri businesses and reeks of corrupt intentions. It is undemocratic and violation of Election Commission guidelines," the All India Kisan Sabha (AIKS) said. It said the decision was taken in a "hasty manner" despite serious concerns expressed by wide sections.

"AIKS requests the Election Commission to intervene to stall this undemocratic move bypassing Parliament and aimed at aiding profiteering by big agri businesses," it said. "The hasty and non-transparent decision of the environment ministry on the eve of announcement of Lok Sabha elections to allow field trials despite the absence of a stringent mechanism to ensure bio-safety as well as a strong regulatory body opened the floodgates for field trials and set in motion these fast-paced developments," it said.

The GEAC, a statutory body for approving GM crops, had yesterday decided to revalidated proposals for wider field trials for 10 GM crops including wheat and rice. Over 70 new proposals including of many food crops will also be examined by GEAC in April.

AIKS said the applications for revalidation were made by companies whose permits had lapsed as they were opposed by states.

The decision will allow Mahyco, BASF India and Monsanto India to go ahead with wider or phase-II field trials for these genetically modified crops.

The rest is here:
Govt nod for GM crop field trials violates EC guidelines, says farmers' body

What is GMO and Agricultural Crops That Have a Risk of Being GMO
GMOs, or "genetically modified organisms," are plants or animals created through the gene splicing techniques of biotechnology (also called genetic engineeri...

By: adsen sensetive

More:
What is GMO and Agricultural Crops That Have a Risk of Being GMO - Video

Nine species of giant, flightless birds, known as moas, suddenly went extinct within two centuries of humans first arrival to New Zealand. Coincidence? No, a team of geneticists, biologists and archeologists recently wrote. The scientists found evidence that moas thrived before Polynesians colonized the islands in the 13th century.

The scientists analyzed genetic remains from 281 individual birds from four species of moa. The researchers looked for signs of dwindling moa populations in the 4,000 years before humans arrived. When animal populations shrink dramatically, their genetic diversity also decreases. Instead, the moa had a healthy variety of DNA, which suggested strong populations.

CSI Fossils: Ancient Killers Caught in the Act

For example, the 3.6 meter (12 ft.) tall South Island giant moa (Dinornis robustus) had an estimated population of 9,200 individuals that may have been growing. Although another species, the 1.5 to 1.8 meter (4.95.9 ft.) tall eastern moa (Euryapteryx crassus), showed signs of a major historical die-off, that reduction in numbers likely occurred more than 17,900 years ago, thousands of years before humans arrived. Euryapteryx crassus had recovered and seemed to be thriving in the eastern lowland forests of New Zealand by the time humans arrived.

BLOG: Humans Acquitted of Mammoth Murder

These findings point strongly toward human contact as the only factor responsible for the extinction, wrote the scientists in Proceedings of the National Academy of Sciences.

Elsewhere the situation may be more complex, but in the case of New Zealand the evidence provided by ancient DNA is now clear: The megafaunal extinctions were the result of human factors, said lead author Mike Bunce of Curtin University in Australia in a press release. We need to be more aware of the impacts we are having on the environment today and what we, as a species, are responsible for in the past.

Illustration: Polynesians Hunting Giant Moa, by Heinrich Harder. Credit: Wikimedia Commons

The rest is here:
Humans Wiped Out Giant New Zealand Bird

Mar 19, 2014 by Robert Sanders Human cardiac myocytes (muscle cells) stained green for proteins encoded by edited genes using the new CRISPR/Cas9 technology.

The University of California, Berkeley, and UC San Francisco are launching the Innovative Genomics Initiative (IGI) to lead a revolution in genetic engineering based on a new technology already generating novel strategies for gene therapy and the genetic study of disease.

The Li Ka Shing Foundation has provided a $10 million gift to support the initiative, establishing the Li Ka Shing Center for Genomic Engineering and an affiliated faculty chair at UC Berkeley. The two universities also will provide $2 million in start-up funds.

At the core of the initiative is a revolutionary technology discovered two years ago at UC Berkeley by Jennifer A. Doudna, executive director of the initiative and the new faculty chair. The technology, precision "DNA scissors" referred to as CRISPR/Cas9, has exploded in popularity since it was first published in June 2012 and is at the heart of at least three start-ups and several heavily-attended international meetings. Scientists have referred to it as the "holy grail" of genetic engineering and a "jaw-dropping" breakthrough in the fight against genetic disease. In honor of her discovery and earlier work on RNA, Doudna received last month the Lurie Prize of the Foundation for the National Institutes of Health.

"Professor Doudna's breakthrough discovery in genomic editing is leading us into a new era of possibilities that we could have never before imagined," said Li Ka-shing, chairman of the Li Ka Shing Foundation. "It is a great privilege for my foundation to engage with two world-class public institutions to launch the Innovative Genomics Initiative in this quest for the holy grail to fight genetic diseases."

In the 18 months since the discovery of this technology was announced, more than 125 papers have been published based on the technique. Worldwide, researchers are using Cas9 to investigate the genetic roots of problems as diverse as sickle cell anemia, diabetes, cystic fibrosis, AIDS and depression in hopes of finding new drug targets. Others are adapting the technology to reengineer yeast to produce biofuels and wheat to resist pests and drought.

"We now have a very easy, very fast and very efficient technique for rewriting the genome, which allows us to do experiments that have been impossible before," said Doudna, a professor of molecular and cell biology in the California Institute for Quantitative Biosciences (QB3) and an investigator in the Howard Hughes Medical Institute at UC Berkeley. "We are grateful to Mr. Li Ka-shing for his support of our initiative, which will propel ground-breaking advances in genomic engineering."

Transforming genetic research

The new genomic engineering technology significantly cuts down the time it takes researchers to test new therapies. CRISPR/Cas 9 allows the creation in weeks rather than years of animal strains that mimic a human disease, allowing researchers to test new therapies. The technique also makes it quick and easy to knock out genes in human cells or in animals to determine their function, which will speed the identification of new drug targets for diseases.

"The CRISPR/Cas9 technology is a complete game changer," said Jonathan Weissman, codirector of the initiative and professor of cellular and molecular pharmacology in the UCSF School of Medicine. "With CRISPR, we can now turn genes off or on at will. I am particularly interested in using CRISPR to understand the normal functions of genes as well as how disease-causing mutations alter these functions."

Continue reading here:
New DNA-editing technology spawns novel strategies for gene therapy

PUBLIC RELEASE DATE:

19-Mar-2014

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 19, 2014The number of menopausal women is projected to reach 50 million by 2020. With changing views on appropriate therapies to control symptoms and new treatments available and on the horizon, most internists lack the core competencies and experience to meet the needs of women entering menopause, according to a provocative Commentary published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://www.liebertpub.com/jwh.

The article "Competency in Menopause Management: Whither Goest the Internist?" by Richard Santen, MD, University of Virginia Health Sciences System (Charlottesville), Cynthia Stuenkel, MD, University of California at San Diego, Henry Burger, MD, Monash University (Melbourne, Australia), and JoAnn Manson, MD, Brigham and Women's Hospital, Harvard Medical School (Boston, MA), describes the changing landscape of menopausal symptom management, with renewed use of hormone therapy among recently menopausal women at low risk of breast cancer and heart disease. The emergence of new non-hormonal treatments and other approaches may be unfamiliar to internists who are often ill-prepared to manage symptoms in women who have completed their reproductive years and are approaching or beginning menopause.

"It is essential that new curricula be developed to train internists in the core competencies needed to manage menopausal symptoms," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

###

About the Journal

Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.liebertpub.com/jwh. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.

About the Academy

See original here:
Internists must play a larger role in managing menopausal symptoms

PUBLIC RELEASE DATE:

17-Mar-2014

Contact: Kathryn Ruehle kruehle@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 17, 2014In response to the 2010 Affordable Care Act, employers may no long offer traditional employee health care benefits as they protect themselves from rising health care costs and seek to minimize their risk. How the shifting landscape of health care coverage will impact population health management providers, employers, and employees is the focus of a commentary in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Population Health Management website at http://www.liebertpub.com/pop.

Bruce Sherman, MD, Case Western Reserve University School of Medicine (Cleveland, OH), and Chris Behling, AXA (New York, NY), explore many potential scenarios and conclude that employees and their families may be most impacted by these changes. In the article "Beyond Incentives: The Impact of Health Care Reform on Employer Population Health Management Strategies", they propose the need for new models of population health management services delivery.

"Sherman and Behling have done a great job outlining the challenges faced by every employer in our nation under health reform," says Editor-in-Chief David B. Nash, MD, MBA, Dean and Dr. Raymond C. and Doris N. Grandon Professor, Jefferson School of Population Health, Philadelphia, PA. "The success of Obamacare rests, in no small part, on following their advice!"

###

About the Journal

Population Health Management is an authoritative peer-reviewed journal published bimonthly in print and online that reflects the expanding scope of health care management and quality. The Journal delivers a comprehensive, integrated approach to the field of population health and provides information designed to improve the systems and policies that affect health care quality, access, and outcomes. Comprised of peer-reviewed original research papers, clinical research, and case studies, the content encompasses a broad range of chronic diseases (such as cardiovascular disease, cancer, chronic pain, diabetes, depression, and obesity) in addition to focusing on various aspects of prevention and wellness. Tables of content and a sample issue may be viewed on the Population Health Management website at http://www.liebertpub.com/pop. Population Health Management is the official journal of the Population Health Alliance.

About the Publisher

Follow this link:
Will health care reform require new population health management strategies?

BERKELEY

The University of California, Berkeley, and UC San Francisco are launching the Innovative Genomics Initiative (IGI) to lead a revolution in genetic engineering based on a new technology already generating novel strategies for gene therapy and the genetic study of disease.

The Li Ka Shing Foundation has provided a $10 million gift to support the initiative, establishing the Li Ka Shing Center for Genomic Engineering and an affiliated faculty chair at UC Berkeley. The two universities also will provide $2 million in start-up funds.

Jennifer Doudna, executive director of the new Innovative Genomics Initiative and the new Li Ka Shing Chancellors Chair in Biomedical and Health Sciences.

At the core of the initiative is a revolutionary technology discovered two years ago at UC Berkeley by Jennifer A. Doudna, executive director of the initiative and the new faculty chair. The technology, precision DNA scissors referred to as CRISPR/Cas9, has exploded in popularity since it was first published in June 2012 and is at the heart of at least three start-ups and several heavily-attended international meetings. Scientists have referred to it as the holy grail of genetic engineering and a jaw-dropping breakthrough in the fight against genetic disease. In honor of her discovery and earlier work on RNA, Doudna received last month the Lurie Prize of the Foundation for the National Institutes of Health.

Professor Doudnas breakthrough discovery in genomic editing is leading us into a new era of possibilities that we could have never before imagined, said Li Ka-shing, chairman of the Li Ka Shing Foundation. It is a great privilege for my foundation to engage with two world-class public institutions to launch the Innovative Genomics Initiative in this quest for the holy grail to fight genetic diseases.

In the 18 months since the discovery of this technology was announced, more than 125 papers have been published based on the technique. Worldwide, researchers are using Cas9 to investigate the genetic roots of problems as diverse as sickle cell anemia, diabetes, cystic fibrosis, AIDS and depression in hopes of finding new drug targets. Others are adapting the technology to reengineer yeast to produce biofuels and wheat to resist pests and drought.

We now have a very easy, very fast and very efficient technique for rewriting the genome, which allows us to do experiments that have been impossible before, said Doudna, a professor of molecular and cell biology in the California Institute for Quantitative Biosciences (QB3) and an investigator in the Howard Hughes Medical Institute at UC Berkeley. We are grateful to Mr. Li Ka-shing for his support of our initiative, which will propel ground-breaking advances in genomic engineering.

Transforming genetic research The new genomic engineering technology significantly cuts down the time it takes researchers to test new therapies. CRISPR/Cas 9 allows the creation in weeks rather than years of animal strains that mimic a human disease, allowing researchers to test new therapies. The technique also makes it quick and easy to knock out genes in human cells or in animals to determine their function, which will speed the identification of new drug targets for diseases.

The CRISPR/Cas9 technology is a complete game changer, said Jonathan Weissman, codirector of the initiative and professor of cellular and molecular pharmacology in the UCSF School of Medicine. With CRISPR, we can now turn genes off or on at will. I am particularly interested in using CRISPR to understand the normal functions of genes as well as how disease-causing mutations alter these functions.

Continued here:
New DNA-editing technology spawns bold UC initiative

PUBLIC RELEASE DATE:

18-Mar-2014

Contact: Kathryn Ruehle kruehle@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 18, 2014Recent high-profile cases have drawn attention to the problem of sexual assault in the U.S. military, the effects on survivors, and the actions and response of military leadership. Issues such as why there is more sexual assault in the military than in the general population, why it is under-reported, and what preventive approaches should the military adopt are explored in a provocative Roundtable Discussion published in the preview issue of Violence and Gender, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Violence and Gender website at http://www.liebertpub.com/vio.

Roundtable participants Mary Ellen O'Toole, PhD, Editor-in-Chief of Violence and Gender and Senior FBI Profiler/Criminal Investigator Analyst (ret.), Christopher Kilmartin, United States Air Force Academy (Colorado Springs), and Colonel Jeffery Peterson, Center for Naval Analyses (Alexandria, VA), discuss specific factors that likely contribute to the sexual assault problem, including the acceptance of bullying in American culture, and an overall greater risk for sexual assault among people who join the military due to more previous experience with sexual assault than the general population, both as offenders and as survivors.

"From the battlefield to Congress, sexual assault in the military is viewed as one of the most concerning criminal problems we face today," says Dr. O'Toole. "Sexual offenders in the military wear the same uniform but victimize innocent men and women who work alongside them to serve their country. As a society we should be outraged at this behavior and want answers. I think we give you some of those answers in this Roundtable Discussion."

###

About the Journal

Violence and Gender is the only peer-reviewed journal focusing on the understanding, prediction, and prevention of acts of violence. Through research papers, roundtable discussions, case studies, and other original content, the Journal critically examines biological, genetic, behavioral, psychological, racial, ethnic, and cultural factors as they relate to the gender of perpetrators of violence. Led by Editor-in-Chief Mary Ellen O'Toole, PhD, Forensic Behavioral Consultant and Senior FBI Profiler/Criminal Investigative Analyst (ret.), Violence and Gender explores the difficult issues that are vital to threat assessment and prevention of the epidemic of violence. Violence and Gender is published quarterly online with Open Access options and in print, and is the official journal of The Avielle Foundation.

About the Publisher

Read this article:
What factors contribute to sexual assault in the military and what can be done to prevent it?

Researchers at Virginia Tech and the Massachusetts Institute of Technology have used a computer-aided design tool to create genetic languages to guide the design of biological systems.

Known as GenoCAD, the open-source software was developed by researchers at the Virginia Bioinformatics Institute at Virginia Tech to help synthetic biologists capture biological rules to engineer organisms that produce useful products or health-care solutions from inexpensive, renewable materials.

GenoCAD helps researchers in the design of protein expression vectors, artificial gene networks, and other genetic constructs, essentially combining engineering approaches with biology.

Synthetic biologists have an increasingly large library of naturally derived and synthetic parts at their disposal to design and build living systems. These parts are the words of a DNA language and the "grammar" a set of design rules governing the language.

It has to be expressive enough to allow scientists to generate a broad range of constructs, but it has to be focused enough to limit the possibilities of designing faulty constructs.

MIT's Oliver Purcell, a postdoctoral associate, and Timothy Lu, an associate professor in the Department of Electrical Engineering and Computer Science, have developed a language detailed in ACS Synthetic Biology describing how to design a broad range of synthetic transcription factors for animals, plants, and other organisms with cells that contain a nucleus.

Meanwhile, Sakiko Okumoto, an assistant professor of plant pathology, physiology, and weed science at the Virginia Tech College of Agriculture and Life Sciences, and Amanda Wilson, a software engineer with the Synthetic Biology Group at the Virginia Bioinformatics Institute, developed a language describing design rules for expressing genes in the chloroplast of microalgae Their work was published in the Jan. 15 issue of Bioinformatics.

"Just like software engineers need different languages like HTML, SQL, or Java to develop different kinds of software applications, synthetic biologists need languages for different biological applications," said Jean Peccoud, an associate professor at the Virginia Bioinformatics Institute, and principal investigator of the GenoCAD project.

"From its inception, we envisioned GenoCAD as a framework allowing users to capture their expertise of a particular domain in languages that they could use themselves or share with others."

The researchers said encapsulating current knowledge by defining standards will become increasingly important as the number and complexity of components engineered by synthetic biologists increases.

See the original post here:
Researchers write languages to design synthetic living systems